The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | Evoli Lisa | SVP, Chief HR Officer | Grant(A) | 12K | — | $0 |
| Dec 18, 2024 | Evoli Lisa | SVP, Chief HR Officer | Disposed to issuer(D) | 12K | — | — |
| Dec 18, 2024 | Evoli Lisa | SVP, Chief HR Officer | Disposed to issuer(D) | 39K | — | — |
| Dec 18, 2024 | Evoli Lisa | SVP, Chief HR Officer | Disposed to issuer(D) | 14K | — | — |
| Dec 18, 2024 | Greisch John J | Executive Chair, Director | Disposed to issuer(D) | 80K | — | — |
| Dec 18, 2024 | Greisch John J | Executive Chair, Director | Disposed to issuer(D) | 34K | — | — |
| Dec 18, 2024 | Greisch John J | Executive Chair, Director | Grant(A) | 34K | — | $0 |
| Dec 18, 2024 | Greisch John J | Executive Chair, Director | Disposed to issuer(D) | 34K | — | — |
| Dec 18, 2024 | Greisch John J | Executive Chair, Director | Disposed to issuer(D) | 127K | — | — |
| Dec 18, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Disposed to issuer(D) | 72K | — | — |
| Dec 18, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Grant(A) | 72K | — | $0 |
| Dec 18, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Disposed to issuer(D) | 76K | — | — |
| Dec 18, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Disposed to issuer(D) | 81K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Grant(A) | 11K | — | $0 |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 30K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 3K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 3K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 3K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 4K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 2K | — | — |
| Dec 18, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Disposed to issuer(D) | 3K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Grant(A) | 113K | — | $0 |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 178K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 113K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 103K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 44K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 16K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 15K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 14K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 10K | — | — |
| Dec 18, 2024 | Maselli Alessandro | President & CEO, Director | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | Barber Michael J | Director | Disposed to issuer(D) | 18K | — | — |
| Dec 18, 2024 | Barg Steven | Director | Disposed to issuer(D) | 12K | — | — |
| Dec 18, 2024 | Carroll J Martin | Director | Disposed to issuer(D) | 33K | — | — |
| Dec 18, 2024 | Classon Rolf A | Director | Disposed to issuer(D) | 48K | — | — |
| Dec 18, 2024 | Damelio Frank A | Director | Disposed to issuer(D) | 13K | — | — |
| Dec 18, 2024 | Lucier Gregory T | Director | Disposed to issuer(D) | 37K | — | — |
| Dec 18, 2024 | Morel Donald E JR | Director | Disposed to issuer(D) | 70K | — | — |
| Dec 18, 2024 | Okey Stephanie | Director | Disposed to issuer(D) | 13K | — | — |
| Dec 18, 2024 | Ryan Michelle R | Director | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | Stahl Jack L | Director | Disposed to issuer(D) | 48K | — | — |
| Dec 18, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Grant(A) | 14K | — | $0 |
| Dec 18, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Disposed to issuer(D) | 24K | — | — |
| Dec 18, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Disposed to issuer(D) | 14K | — | — |
| Dec 18, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Disposed to issuer(D) | 13K | — | — |
| Dec 18, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Disposed to issuer(D) | 40K | — | — |
| Dec 18, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Grant(A) | 13K | — | $0 |
| Dec 18, 2024 | Hatzfeld Michael | Chief Accounting Officer | Disposed to issuer(D) | 3K | — | — |
| Dec 18, 2024 | Hatzfeld Michael | Chief Accounting Officer | Disposed to issuer(D) | 14K | — | — |
| Dec 18, 2024 | Hatzfeld Michael | Chief Accounting Officer | Grant(A) | 3K | — | $0 |
| Dec 18, 2024 | McErlane David | Group President, Biologics | Grant(A) | 11K | — | $0 |
| Dec 18, 2024 | McErlane David | Group President, Biologics | Disposed to issuer(D) | 11K | — | — |
| Dec 18, 2024 | McErlane David | Group President, Biologics | Disposed to issuer(D) | 36K | — | — |
| Dec 18, 2024 | McErlane David | Group President, Biologics | Disposed to issuer(D) | 15K | — | — |
| Dec 18, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Disposed to issuer(D) | 22K | — | — |
| Dec 18, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Grant(A) | 22K | — | $0 |
| Dec 18, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Disposed to issuer(D) | 114K | — | — |
| Nov 11, 2024 | Ryan Michelle R | Director | Sell(S) | 3K | $59.70 | $167K |
| Oct 30, 2024 | Stahl Jack L | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Classon Rolf A | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Lucier Gregory T | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Carroll J Martin | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Morel Donald E JR | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Barber Michael J | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Damelio Frank A | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Okey Stephanie | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Ryan Michelle R | Director | Grant(A) | 5K | — | $0 |
| Oct 30, 2024 | Barg Steven | Director | Grant(A) | 5K | — | $0 |
| Oct 18, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Sell(S) | 320 | $59.97 | $19K |
| Sep 26, 2024 | McErlane David | Group President, Biologics | Sell(S) | 2K | $59.97 | $120K |
| Aug 2, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Sell(S) | 1K | $59.55 | $70K |
| Aug 2, 2024 | Evoli Lisa | SVP, Chief HR Officer | Sell(S) | 4K | $59.67 | $230K |
| Aug 2, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Sell(S) | 608 | $59.58 | $36K |
| Aug 2, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Sell(S) | 666 | $59.55 | $40K |
| Aug 2, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Sell(S) | 662 | $59.56 | $39K |
| Jul 29, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Sell(S) | 349 | $58.70 | $20K |
| Jul 29, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Sell(S) | 283 | $58.69 | $17K |
| Jul 29, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Sell(S) | 206 | $58.67 | $12K |
| Jul 29, 2024 | Maselli Alessandro | President & CEO, Director | Sell(S) | 9K | $58.76 | $534K |
| Jul 26, 2024 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Grant(A) | 19K | — | $0 |
| Jul 26, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Grant(A) | 11K | — | $0 |
| Jul 26, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Grant(A) | 10K | — | $0 |
| Jul 26, 2024 | Maselli Alessandro | President & CEO, Director | Grant(A) | 99K | — | $0 |
| Jul 26, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Jul 26, 2024 | Evoli Lisa | SVP, Chief HR Officer | Grant(A) | 15K | — | $0 |
| Jul 26, 2024 | Ferraro Joseph Anthony | SVP, General Counsel, CCO | Grant(A) | 17K | — | $0 |
| Jul 26, 2024 | McErlane David | Group President, Biologics | Grant(A) | 19K | — | $0 |
| Jul 26, 2024 | Hatzfeld Michael | Chief Accounting Officer | Grant(A) | 6K | — | $0 |
| Jul 26, 2024 | Greisch John J | Executive Chair, Director | Grant(A) | 64K | — | $0 |
| Jul 8, 2024 | Masanovich Matti | SVP, Chief Financial Officer | Sell(S) | 3K | $56.74 | $170K |
| Jun 4, 2024 | Hopson Ricky | Pres. BioProduct Delivery, CoS | Sell(S) | 1K | $54.26 | $76K |
| Mar 15, 2024 | Gunther Scott | SVP, Quality & Reg. Affairs | Sell(S) | 387 | $56.20 | $22K |
| Jan 25, 2024 | Kreuzburg Christa | Director | Tax withholding(F) | 523 | $50.41 | $26K |
| Jan 16, 2024 | Hatzfeld Michael | Chief Accounting Officer | Grant(A) | 6K | — | $0 |
| Jan 16, 2024 | Hatzfeld Michael | Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Jan 16, 2024 | Hatzfeld Michael | Chief Accounting Officer | Grant(A) | 4K | — | $0 |
| Dec 8, 2023 | Hopson Ricky | Pres. Clinical Dev Supply Div | Grant(A) | 747 | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).